[ORGANIZATION]
Rasonque
Featured in 1 tracked story · first seen
Situations
FDA grants expedited approval for daraxonrasib
32 clusters · 148 sources · last updated
Latest: FDA approves daraxonrasib pill to treat metastatic pancreatic cancer
The rolling EMA review of the oral KRAS-targeting inhibitor daraxonrasib, launched on 7 July 2026, continues as new clinical data emerge. A multinational phase-III trial reported on 25 July that daraxonrasib doubled medi